Histological transformation and secondary malignancies in follicular lymphoma

0 / 5 (0 votos)

The Lancet Haematology

Fecha de publicación: 01 november 2018

DOI: https://doi.org/10.1016/S2352-3026(18)30170-4

Autores: Umberto Vitolo., Annalisa Chiappella.

Background: Standard therapy for patients with advanced follicular lymphoma who require treatment is induction chemotherapy in combination with monoclonal antibody anti-CD20 and rituximab, followed by rituximab maintenance. 

Seguir leyendo